Systemic capillary leak syndrome preceding plasma cell leukaemia

Kanjaksha Ghosh, Manisha Madkaikar, Yegneshwar Iyer, Anil Pathare, Farah Jijina, Dipika Mohanty

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We report a patient with plasma cell leukaemia with systemic capillary leak syndrome, a rare disorder often associated with monoclonal gammopathy. In this patient, the manifestation of capillary leak syndrome antedated the diagnosis of plasma cell leukaemia by 5-6 months. During that time, he was repeatedly admitted to the hospital with weight gain, congestive cardiac failure, cough and anasarca in the presence of normal renal function, liver function and normal echocardiography. On presentation, a serum protein electrophoresis showed monoclonal IgG; the blood smear showed 60% plasma cells with a total count of 4.4 × 109/I. A bone marrow aspirate showed replacement of the normal marrow by sheets of immature plasma cells. His systemic capillary leak syndrome initially responded to decongestive therapy with terbutaline and aminophylline but later on he became refractory to them and responded to vincristine, doxorubicin and dexamethasone (VAD) combination therapy only transiently. Danocrine and oxypentiphylline, added during VAD chemotherapy, did not produce a durable response in capillary leak syndrome, which finally responded to autologous peripheral blood stem cell transplantation (PBSCT). After PBSCT, he remained free of capillary leak for 10 months without terbutaline, oxypentiphylline corticosteroids, aminophylline or danocrine. His disease relapsed without recurrence of the capillary leak. He died 15 months after PBSCT and 20 months after the diagnosis of plasma cell leukaemia.

Original languageEnglish
Pages (from-to)118-121
Number of pages4
JournalActa Haematologica
Volume106
Issue number3
DOIs
Publication statusPublished - 2001

Fingerprint

Capillary Leak Syndrome
Plasma Cell Leukemia
Peripheral Blood Stem Cell Transplantation
Danazol
Terbutaline
Aminophylline
Vincristine
Plasma Cells
Doxorubicin
Dexamethasone
Bone Marrow
Paraproteinemias
Cough
Weight Gain
Echocardiography
Electrophoresis
Blood Proteins
Edema
Adrenal Cortex Hormones
Heart Failure

Keywords

  • Capillary leak syndrome
  • Improved survival
  • Monoclonal gammopathy
  • Peripheral blood stem cell transplantation
  • Plasma cell leukaemia

ASJC Scopus subject areas

  • Hematology

Cite this

Ghosh, K., Madkaikar, M., Iyer, Y., Pathare, A., Jijina, F., & Mohanty, D. (2001). Systemic capillary leak syndrome preceding plasma cell leukaemia. Acta Haematologica, 106(3), 118-121. https://doi.org/10.1159/000046600

Systemic capillary leak syndrome preceding plasma cell leukaemia. / Ghosh, Kanjaksha; Madkaikar, Manisha; Iyer, Yegneshwar; Pathare, Anil; Jijina, Farah; Mohanty, Dipika.

In: Acta Haematologica, Vol. 106, No. 3, 2001, p. 118-121.

Research output: Contribution to journalArticle

Ghosh, K, Madkaikar, M, Iyer, Y, Pathare, A, Jijina, F & Mohanty, D 2001, 'Systemic capillary leak syndrome preceding plasma cell leukaemia', Acta Haematologica, vol. 106, no. 3, pp. 118-121. https://doi.org/10.1159/000046600
Ghosh, Kanjaksha ; Madkaikar, Manisha ; Iyer, Yegneshwar ; Pathare, Anil ; Jijina, Farah ; Mohanty, Dipika. / Systemic capillary leak syndrome preceding plasma cell leukaemia. In: Acta Haematologica. 2001 ; Vol. 106, No. 3. pp. 118-121.
@article{bbb70d1f1bff4676b40ffd0133c5944c,
title = "Systemic capillary leak syndrome preceding plasma cell leukaemia",
abstract = "We report a patient with plasma cell leukaemia with systemic capillary leak syndrome, a rare disorder often associated with monoclonal gammopathy. In this patient, the manifestation of capillary leak syndrome antedated the diagnosis of plasma cell leukaemia by 5-6 months. During that time, he was repeatedly admitted to the hospital with weight gain, congestive cardiac failure, cough and anasarca in the presence of normal renal function, liver function and normal echocardiography. On presentation, a serum protein electrophoresis showed monoclonal IgG; the blood smear showed 60{\%} plasma cells with a total count of 4.4 × 109/I. A bone marrow aspirate showed replacement of the normal marrow by sheets of immature plasma cells. His systemic capillary leak syndrome initially responded to decongestive therapy with terbutaline and aminophylline but later on he became refractory to them and responded to vincristine, doxorubicin and dexamethasone (VAD) combination therapy only transiently. Danocrine and oxypentiphylline, added during VAD chemotherapy, did not produce a durable response in capillary leak syndrome, which finally responded to autologous peripheral blood stem cell transplantation (PBSCT). After PBSCT, he remained free of capillary leak for 10 months without terbutaline, oxypentiphylline corticosteroids, aminophylline or danocrine. His disease relapsed without recurrence of the capillary leak. He died 15 months after PBSCT and 20 months after the diagnosis of plasma cell leukaemia.",
keywords = "Capillary leak syndrome, Improved survival, Monoclonal gammopathy, Peripheral blood stem cell transplantation, Plasma cell leukaemia",
author = "Kanjaksha Ghosh and Manisha Madkaikar and Yegneshwar Iyer and Anil Pathare and Farah Jijina and Dipika Mohanty",
year = "2001",
doi = "10.1159/000046600",
language = "English",
volume = "106",
pages = "118--121",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Systemic capillary leak syndrome preceding plasma cell leukaemia

AU - Ghosh, Kanjaksha

AU - Madkaikar, Manisha

AU - Iyer, Yegneshwar

AU - Pathare, Anil

AU - Jijina, Farah

AU - Mohanty, Dipika

PY - 2001

Y1 - 2001

N2 - We report a patient with plasma cell leukaemia with systemic capillary leak syndrome, a rare disorder often associated with monoclonal gammopathy. In this patient, the manifestation of capillary leak syndrome antedated the diagnosis of plasma cell leukaemia by 5-6 months. During that time, he was repeatedly admitted to the hospital with weight gain, congestive cardiac failure, cough and anasarca in the presence of normal renal function, liver function and normal echocardiography. On presentation, a serum protein electrophoresis showed monoclonal IgG; the blood smear showed 60% plasma cells with a total count of 4.4 × 109/I. A bone marrow aspirate showed replacement of the normal marrow by sheets of immature plasma cells. His systemic capillary leak syndrome initially responded to decongestive therapy with terbutaline and aminophylline but later on he became refractory to them and responded to vincristine, doxorubicin and dexamethasone (VAD) combination therapy only transiently. Danocrine and oxypentiphylline, added during VAD chemotherapy, did not produce a durable response in capillary leak syndrome, which finally responded to autologous peripheral blood stem cell transplantation (PBSCT). After PBSCT, he remained free of capillary leak for 10 months without terbutaline, oxypentiphylline corticosteroids, aminophylline or danocrine. His disease relapsed without recurrence of the capillary leak. He died 15 months after PBSCT and 20 months after the diagnosis of plasma cell leukaemia.

AB - We report a patient with plasma cell leukaemia with systemic capillary leak syndrome, a rare disorder often associated with monoclonal gammopathy. In this patient, the manifestation of capillary leak syndrome antedated the diagnosis of plasma cell leukaemia by 5-6 months. During that time, he was repeatedly admitted to the hospital with weight gain, congestive cardiac failure, cough and anasarca in the presence of normal renal function, liver function and normal echocardiography. On presentation, a serum protein electrophoresis showed monoclonal IgG; the blood smear showed 60% plasma cells with a total count of 4.4 × 109/I. A bone marrow aspirate showed replacement of the normal marrow by sheets of immature plasma cells. His systemic capillary leak syndrome initially responded to decongestive therapy with terbutaline and aminophylline but later on he became refractory to them and responded to vincristine, doxorubicin and dexamethasone (VAD) combination therapy only transiently. Danocrine and oxypentiphylline, added during VAD chemotherapy, did not produce a durable response in capillary leak syndrome, which finally responded to autologous peripheral blood stem cell transplantation (PBSCT). After PBSCT, he remained free of capillary leak for 10 months without terbutaline, oxypentiphylline corticosteroids, aminophylline or danocrine. His disease relapsed without recurrence of the capillary leak. He died 15 months after PBSCT and 20 months after the diagnosis of plasma cell leukaemia.

KW - Capillary leak syndrome

KW - Improved survival

KW - Monoclonal gammopathy

KW - Peripheral blood stem cell transplantation

KW - Plasma cell leukaemia

UR - http://www.scopus.com/inward/record.url?scp=0035165124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035165124&partnerID=8YFLogxK

U2 - 10.1159/000046600

DO - 10.1159/000046600

M3 - Article

C2 - 11713377

AN - SCOPUS:0035165124

VL - 106

SP - 118

EP - 121

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 3

ER -